The relationship between DGKα expression and cancer progression has been reported in several cancers, including hepatocellular carcinoma, melanoma, glioblastoma, colon adenocarcinoma, and breast adenocarcinoma [15, 16, 17, 18]. This evidence concerns the gene DGKA and hepatocellular carcinoma.